Lamivudine Clinical Trials

• Study of Treatment of Antiretroviral-Naive, HIV-1-Infected Patients Comparing Tenofovir Disoproxil Fumarate Administered in Combination with Lamivudine and Efavirenz Vs. Stavudine, Lamivudine and Efavirenz.
  ClinicalTrials.gov Identifier: NCT00158821 - Active, not recruiting
  HIV-1
  
• Comparison of Anti-HIV Drug Combinations to Prevent Mother-to-Child Transmission of HIV
  ClinicalTrials.gov Identifier: NCT00086359 - Active, not recruiting
  HIV Infections
  
• A Study to Evaluate the Safety and Tolerance of Stavudine (d4T) in Combination with Lamivudine (3TC) in HIV-Positive Pregnant Women and Their Infants
  ClinicalTrials.gov Identifier: NCT00000878 - Active, not recruiting
  HIV Infections; Pregnancy
  
• Safety and Effectiveness of Giving Indinavir Plus Stavudine Plus Lamivudine to HIV-Infected Children
  ClinicalTrials.gov Identifier: NCT00000901 - Active, not recruiting
  HIV Infections
  
• Zidovudine and Lamivudine Given Once Versus Twice Daily
  ClinicalTrials.gov Identifier: NCT00014014 - Active, not recruiting
  HIV Infections
  
• A Study to Evaluate the Safety and Tolerance of Nelfinavir (NFV) Given with Zidovudine (ZDV) and Lamivudine (3TC) in HIV-Positive Pregnant Women and Their Infants
  ClinicalTrials.gov Identifier: NCT00000887 - Active, not recruiting
  HIV Infections; Pregnancy
  
• Zidovudine / Lamivudine + Nevirapine Twice Daily, Versus Tenofovir + Lamivudine + Nevirapine Once Daily in ARV-Naive Patients
  ClinicalTrials.gov Identifier: NCT00199979 - Recruiting
  Hiv Infection With Antiretroviral Therapy Indication; CD4 Below 350/µL or Below 15%
  
• A Study to Evaluate the Safety and Tolerance of Combination Anti-HIV Drug Therapy (Indinavir, Lamivudine, and Zidovudine) in HIV-Positive Pregnant Women and Their Infants
  ClinicalTrials.gov Identifier: NCT00000944 - Active, not recruiting
  HIV Infections; Pregnancy
  
• Safety and Effectiveness of Three Anti-HIV Drugs Combined in One Pill (Trizivir)
  ClinicalTrials.gov Identifier: NCT00004981 - Active, not recruiting
  HIV Infections
  
• Safety and Effectiveness of Giving Indinavir, Ritonavir, Stavudine, and Lamivudine to HIV-Infected Patients Who Have Never Received Anti-HIV Drugs
  ClinicalTrials.gov Identifier: NCT00002451 - Active, not recruiting
  HIV Infections
  
• Four-Drug Combination Therapy with Zidovudine, Lamivudine, 1592U89 (Abacavir), and 141W94 (Amprenavir) in HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00006617 - Active, not recruiting
  HIV Infections
  
• Switching Study From Lamivudine to Clevudine Versus Continued Lamivudine in the Chronic Hepatitis B Patients
  ClinicalTrials.gov Identifier: NCT00558493 - Recruiting
  Chronic Hepatitis B
  
• Safety and Effectiveness of TRIZIVIR (Abacavir/Lamivudine/Zidovudine) with Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs
  ClinicalTrials.gov Identifier: NCT00011895 - Active, not recruiting
  HIV Infections
  
• Study of Anti-HIV Therapy Intensification
  ClinicalTrials.gov Identifier: NCT00034086 - Active, not recruiting
  HIV Infections
  
• Comparison of GW433908/Ritonavir to Nelfinavir When Used with Abacavir and Lamivudine in Patients That Have Not Taken Antiretroviral Drugs
  ClinicalTrials.gov Identifier: NCT00009061 - Active, not recruiting
  HIV Infections
  
• Lamivudine and Therapeutic Vaccine Evaluation in Senegalese Patients with Chronic Hepatitis B Infection
  ClinicalTrials.gov Identifier: NCT00120796 - Recruiting
  Hepatitis B
  
• Safety of and Immune Response to Cyclosporine A in Combination with Abacavir Sulfate, Lamivudine, and Zidovudine and Lopinavir/Ritonavir in Adults with Acute HIV Infection
  ClinicalTrials.gov Identifier: NCT00084149 - Active, not recruiting
  HIV Infections
  
• PI Vs. NNRTI Based Therapy for HIV Advanced Disease
  ClinicalTrials.gov Identifier: NCT00162643 - Recruiting
  Acquired Immunodeficiency Syndrome
  
• Trial of UK-427,857 in Combination with Zidovudine/Lamivudine versus Efavirenz in Combination with Zidovudine/Lamivudine for the Treatment of HIV-1 Infected Subjects
  ClinicalTrials.gov Identifier: NCT00098293 - Active, not recruiting
  HIV Infection
  
• Telbivudine versus Lamivudine in Adults with Decompensated Chronic Hepatitis B and Evidence of Cirrhosis
  ClinicalTrials.gov Identifier: NCT00076336 - Active, not recruiting
  Hepatitis; Hepatitis B, Chronic; Cirrhosis
  
• Efavirenz Or Atazanazir/Ritonavir Given with Emtricitabine/Tenofovir Disoproxil Fumarate Or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults
  ClinicalTrials.gov Identifier: NCT00118898 - Active, not recruiting
  HIV Infections
  
• Study Comparing the Safety of Switching From Lamivudine to Adefovir Dipivoxil Versus Overlapping Lamivudine and Adefovir Before Adefovir Dipivoxil Monotherapy in Patients With Chronic Hepatitis B
  ClinicalTrials.gov Identifier: NCT00307242 - Recruiting
  Chronic Hepatitis B
  
• Study of Zidovudine/Lamivudine and Nevirapine for Reduction of Mother-to-Child HIV Transmission During Breastfeeding
  ClinicalTrials.gov Identifier: NCT00146380 - Recruiting
  HIV Infections
  
• A Randomized, Prospective Study of the Efficacy, Safety and Tolerability of Two Doses of GW433908Ritonavir Given With Abacavir/Lamivudine Fixed Dose Combination
  ClinicalTrials.gov Identifier: NCT00335270 - Active, not recruiting
  HIV
  
• Abacavir/Lamivudine Versus Emtricitabine/Tenofovir Both In Combination With Lopinavir/Ritonavir For The Treatment Of HIV
  ClinicalTrials.gov Identifier: NCT00244712 - Active, not recruiting
  HIV Infections
  
• Efavirenz and Lamivudine/Zidovudine for Treatment-Naive HIV Infected Adults and Adolescents in Senegal
  ClinicalTrials.gov Identifier: NCT00100568 - Not yet recruiting
  HIV Infections
  
• A Study to Investigate Whether the Immediate Use or Deferred Use of an Anti-Viral Drug Lamivudine Will Help to Better Safe-Guard the Delivery of Chemotherapy in Patients With Cancer Who Are Also Hepatitis B Carriers
  ClinicalTrials.gov Identifier: NCT00516945 - Active, not recruiting
  Hepatitis B; Neoplasms
  
• An Extension Study of Telbivudine, Lamivudine or Telbivudine Plus Lamivudine in Patients With Chronic Hepatitis B
  ClinicalTrials.gov Identifier: NCT00124241 - Completed
  Hepatitis B
  
• Induction/Simplification With Atazanavir + Ritonavir + Abacavir/Lamivudine Fixed-Dose Combination In HIV-1 Infection
  ClinicalTrials.gov Identifier: NCT00440947 - Active, not recruiting
  HIV Infection
  
• Different Regimens of Pegylated Interferon and Lamivudine Combination Therapy in Chronic Hepatitis B Patients
  ClinicalTrials.gov Identifier: NCT00226447 - Active, not recruiting
  Chronic Hepatitis B
  
• A Trial To Study The Effect Of Lamivudine In Adult Patients Who Suffer From Chronic Hepatitis B Alone
  ClinicalTrials.gov Identifier: NCT00354653 - Active, not recruiting
  Chronic Hepatitis B
  
• Safety and Effectiveness of an Anti-HIV Drug Combination Taken Twice Daily
  ClinicalTrials.gov Identifier: NCT00002241 - Active, not recruiting
  HIV Infections
  
• Bioavailability Study of a New Pediatric Formulation of Zidovudine/Lamivudine in Adult Volunteers
  ClinicalTrials.gov Identifier: NCT00470041 - Recruiting
  Healthy
  
• NRTI-Sparing Pilot Study
  ClinicalTrials.gov Identifier: NCT00143689 - Active, not recruiting
  HIV; Mitochondrial Toxicity
  
• Switching Therapy from Lamivudine to Telbivudine Vs Continued Lamivudine in Adults with Chronic Hepatitis B
  ClinicalTrials.gov Identifier: NCT00132652 - Completed
  Chronic Hepatitis B
  
• Comparison of Elvucitabine/Efavirenz/Tenofovir Versus Lamivudine/Efavirenz/Tenofovir in HIV-1 Infected, Treatment Naive Subjects
  ClinicalTrials.gov Identifier: NCT00350272 - Active, not recruiting
  HIV Infections
  
• Comparison of Three Different Initial Treatments Without Protease Inhibitors for HIV Infection
  ClinicalTrials.gov Identifier: NCT00013520 - Completed
  HIV Infections
  
• Treatment with Combinations of Several Antiviral Drugs in Infants and Young Children with HIV Infection
  ClinicalTrials.gov Identifier: NCT00000872 - Active, not recruiting
  HIV Infections
  
• Treatment with Interleukin-2 (IL-2) Plus Combination Anti-HIV-Drug Therapy (HAART) for Patients Formerly in ACTG 328
  ClinicalTrials.gov Identifier: NCT00000923 - Active, not recruiting
  HIV Infections
  
• A Study of the Safety and Effectiveness of Treating Advanced AIDS Patients between Ages 4 and 22 with 7 Drugs, Some at Higher than Usual Doses
  ClinicalTrials.gov Identifier: NCT00001108 - Active, not recruiting
  HIV Infections
  
• Anti-HIV Drugs for Treating Infants Who Acquired HIV Infection at Birth
  ClinicalTrials.gov Identifier: NCT00102960 - Active, not recruiting
  HIV Infections
  
• Use of Combined Antiretroviral Therapy to Determine Sites of Persistent HIV Infection
  ClinicalTrials.gov Identifier: NCT00001644 - Active, not recruiting
  HIV Infection
  
• Comparing the Safety, Effectiveness, and Tolerability of Three Anti-HIV Drug Regimens for Treatment-Naive Patients
  ClinicalTrials.gov Identifier: NCT00050895 - Active, not recruiting
  HIV Infections
  
• Once-Daily HAART Regimen Administration in HIV-1 Infected Children in Burkina Faso
  ClinicalTrials.gov Identifier: NCT00122538 - Active, not recruiting
  HIV Infection; AIDS
  
• A Comparison of Two Anti-HIV Drug Regimens for Youth Who Have Failed Prior Therapy
  ClinicalTrials.gov Identifier: NCT00102206 - Active, not recruiting
  HIV Infections
  
• A Study on the Management of Combination Anti-HIV Drug Therapy in HIV-Positive Children with Prior Treatment
  ClinicalTrials.gov Identifier: NCT00000902 - Active, not recruiting
  HIV Infections
  
• A Study of ABT-378/Ritonavir in HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00004578 - Active, not recruiting
  HIV Infections
  
• Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected with HIV
  ClinicalTrials.gov Identifier: NCT00000940 - Active, not recruiting
  HIV Infections
  
• Once-Daily PI/NNRTI Therapy Combinations for Treatment Naive, HIV Infected Patients in Resource-limited Conditions
  ClinicalTrials.gov Identifier: NCT00084136 - Active, not recruiting
  HIV Infections
  
• A Study of Ritonavir (an Anti-HIV Drug) in HIV-Positive Infants and Children
  ClinicalTrials.gov Identifier: NCT00000952 - Active, not recruiting
  HIV Infections
  
• Compare the Efficacy and Safety of 48-Week Treatment With Clevudine 30mg Versus Lamivudine 100mg for CHB Infection
  ClinicalTrials.gov Identifier: NCT00362635 - Recruiting
  Hepatitis B
  
• Anti-HIV Treatment Interruptions in HIV Infected Adults in South Africa
  ClinicalTrials.gov Identifier: NCT00100646 - Active, not recruiting
  HIV Infections
  
• Effectiveness of Treating HIV-Positive Patients with an HIV Vaccine (Remune)
  ClinicalTrials.gov Identifier: NCT00005002 - Active, not recruiting
  HIV Infections
  
• HIV Study Of GW433908 Versus Kaletra, Both With Abacavir/lamivudine In Therapy-Naive Patients
  ClinicalTrials.gov Identifier: NCT00085943 - Active, not recruiting
  HIV Infections
  
• Comparison of GW433908 and Nelfinavir in HIV Patients Who Have Not Had Antiretroviral Therapy
  ClinicalTrials.gov Identifier: NCT00008554 - Active, not recruiting
  HIV Infections
  
• Long-Term Lamivudine Therapy for Chronic Hepatitis B
  ClinicalTrials.gov Identifier: NCT00120354 - Completed
  
  
• Treatment with Nelfinavir or Efavirenz of HIV-Infected Patients Who Have Never Received Anti-HIV Drugs
  ClinicalTrials.gov Identifier: NCT00005000 - Active, not recruiting
  HIV Infections
  
• Effectiveness of Directly Observed Therapy in Combined HIV and Tuberculosis Treatment in Resource-limited Settings
  ClinicalTrials.gov Identifier: NCT00091936 - Active, not recruiting
  HIV Infections; Tuberculosis
  
• A Randomized Study Comparing Lamivudine Versus Adefovir Dipivoxil for Prevention of zHBV Reactivation in HBsAg Seropositive Patients Undergoing Cytotoxic Chemotherapy
  ClinicalTrials.gov Identifier: NCT00489151 - Recruiting
  Hepatitis B
  
• Treatment of Hepatitis B Virus (HBV) Before Beginning Anti-HIV Drugs in Patients with Both HBV and HIV
  ClinicalTrials.gov Identifier: NCT00051090 - Active, not recruiting
  HIV Infections; Hepatitis B
  
• Drug Levels of Tablet and Liquid Forms of Lamivudine, Nevirapine, and Stavudine in HIV Infected Thai Children
  ClinicalTrials.gov Identifier: NCT00312091 - Recruiting
  HIV Infections
  
• Safety and antiviral study of ACH126, 433 (b-L-Fd4C) in adults with lamivudine-resistant chronic hepatitis B
  ClinicalTrials.gov Identifier: NCT00040144 - Active, not recruiting
  Chronic Hepatitis B
  
• 3TC (Lamivudine; GR109714X) Open-Label Program
  ClinicalTrials.gov Identifier: NCT00002108 - Completed
  HIV Infections
  
• MEDICLAS Study (Metabolic Effects of Different Classes of AntiretroviralS)
  ClinicalTrials.gov Identifier: NCT00122226 - Active, not recruiting
  HIV Infections; HIV-Associated Lipodystrophy Syndrome
  
• Adding Adefovir Dipivoxil Versus Switching to Entecavir in Patients With Lamivudine-Resistant Chronic Hepatitis B
  ClinicalTrials.gov Identifier: NCT00531167 - Recruiting
  Chronic Hepatitis B
  
• A Study of PEGASYS® (Peginterferon Alfa-2a (40KD)) in Patients With Lamivudine Resistant HBeAg-Negative Chronic Hepatitis B.
  ClinicalTrials.gov Identifier: NCT00460850 - Recruiting
  Hepatitis B, Chronic
  
• A Study in Korea of Entecavir Versus Lamivudine in Adults With Chronic Hepatitis B Infection
  ClinicalTrials.gov Identifier: NCT00393484 - Recruiting
  Chronic Hepatitis B
  
• Lamivudine as an Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular Carcinoma
  ClinicalTrials.gov Identifier: NCT00555334 - Recruiting
  Hepatocellular Carcinoma; Liver Cancer
  
• A Study to Compare the Safety and Effectiveness of Two Dosing Schedules of Lamivudine in Combination with Two Other Anti-HIV Drugs
  ClinicalTrials.gov Identifier: NCT00002442 - Completed
  HIV Infections
  
• A Comparison of Three Anti-HIV Drug Combinations in HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00005106 - Completed
  HIV Infections
  
• Comparing FTC and Lamivudine in HIV-Infected Patients on a Stable Anti-HIV Drug Combination
  ClinicalTrials.gov Identifier: NCT00002416 - Completed
  HIV Infections
  
• Once a Day (QD) - Twice a Day (BID) Clinical Trial: Didanosine, Lamivudine and Efavirenz Versus Zidovudine, Lamivudine and Efavirenz in the Starting Treatment of HIV
  ClinicalTrials.gov Identifier: NCT00256828 - Completed
  HIV Infections
  
• Tenofovir Disoproxil Fumarate (DF)/Emtricitabine/Efavirenz Versus Combivir/Efavirenz in Antiretroviral-Naive HIV-1 Infected Subjects
  ClinicalTrials.gov Identifier: NCT00112047 - Active, not recruiting
  HIV Infections
  
• Effectiveness and Safety of Epivir/Ziagen/Zerit (3TC/ABC/d4T) Versus Epivir/Ziagen/Sustiva (3TC/ABC/EFV) Versus Epivir/Ziagen/Agenerase/Norvir (3TC/ABC/APV/RTV) in HIV Patients Who Have Never Received Treatment
  ClinicalTrials.gov Identifier: NCT00005017 - Active, not recruiting
  HIV Infections
  
• Lamivudine Plus Interferon Versus Lamivudine For The Treatment Of HBeAg Positive Chronic Hepatitis B Virus (HBV)
  ClinicalTrials.gov Identifier: NCT00140725 - Completed
  HBeAg positive chronic hepatitis B patients with active disease
  
• The STEAL Study
  ClinicalTrials.gov Identifier: NCT00192634 - Recruiting
  HIV
  
• Effectiveness of Adding Interleukin-2 to Anti-HIV Drugs in Patients Recently Infected with HIV
  ClinicalTrials.gov Identifier: NCT00006441 - Recruiting
  HIV Infections
  
• A Study of Increased Lactic Acid and Abnormal Fat Distribution in HIV-Positive Patients
  ClinicalTrials.gov Identifier: NCT00005764 - Completed
  HIV Infections; Lipodystrophy
  
• When to Start Anti-HIV Drugs in Children Infected With HIV
  ClinicalTrials.gov Identifier: NCT00234091 - Recruiting
  HIV Infections
  
• Potent Antiviral Therapy for Critically Ill HIV Infected Patients Admitted to Intensive Care
  ClinicalTrials.gov Identifier: NCT00028327 - Completed
  HIV Infections
  
• Evaluation of Four Anti-HIV Treatment Strategies in Resource-Limited South African Communities
  ClinicalTrials.gov Identifier: NCT00255840 - Active, not recruiting
  HIV Infections
  
• Early Versus Standard Start of Anti-HIV Therapy for Treatment-Naive Adults in Haiti
  ClinicalTrials.gov Identifier: NCT00120510 - Recruiting
  HIV Infections; Tuberculosis
  
• The Safety and Effectiveness of Lamivudine Plus Zidovudine, Used with and without 1592U89, in HIV-1 Infected Patients Who Have Never Taken Anti-HIV Drugs
  ClinicalTrials.gov Identifier: NCT00002389 - Completed
  HIV Infections
  
• The Safety and Effectiveness of Zidovudine Plus Lamivudine, Used with and without 1592U89, in HIV-1 Infected Children Who Have Taken Anti-HIV-1 Drugs
  ClinicalTrials.gov Identifier: NCT00002391 - Completed
  HIV Infections
  
• Randomized, Double Blind Trial of LdT (Telbivudine) versus Lamivudine in Adults with Compensated Chronic Hepatitis B
  ClinicalTrials.gov Identifier: NCT00057265 - Completed
  Chronic Hepatitis B
  
• Comparison of Three Anti-HIV Regimens to Prevent Nevirapine Resistance in Women who Take Nevirapine During Pregnancy
  ClinicalTrials.gov Identifier: NCT00099632 - Recruiting
  HIV Infections
  
• Entecavir Plus Adefovir Versus Entecavir or Adefovir Monotherapy for Chronic Hepatitis B Infected Subjects With Lamivudine-Resistant Virus
  ClinicalTrials.gov Identifier: NCT00410202 - Recruiting
  Hepatitis B, Chronic
  
• A Comparison of Zidovudine Plus Lamivudine Versus ddI Used Alone or in Combination with Zidovudine in HIV-1 Infected Children
  ClinicalTrials.gov Identifier: NCT00001066 - Completed
  HIV Infections
  
• A Comparison of BMS-232632 with Efavirenz, Each in Combination with Zidovudine-Lamivudine
  ClinicalTrials.gov Identifier: NCT00013897 - Completed
  HIV Infections
  
• Simplified Drug Regimens for HIV Patients in ACTG 388 or Patients Who Responded to A First Potent Combination Regimen
  ClinicalTrials.gov Identifier: NCT00014937 - Completed
  HIV Infections
  
• The Safety and Effectiveness of Nevirapine Plus Lamivudine Plus Other Anti-HIV Drugs
  ClinicalTrials.gov Identifier: NCT00002368 - Completed
  HIV Infections
  
• Preventing Sexual Transmission of HIV With Anti-HIV Drugs
  ClinicalTrials.gov Identifier: NCT00074581 - Completed
  HIV Infections; HIV Seronegativity
  
• Efavirenz and Lamivudine/Zidovudine for Treatment-Naive HIV Infected People in Wenxi County, Shanxi Province, China
  ClinicalTrials.gov Identifier: NCT00100594 - Completed
  HIV Infections
  
• A Study of Three Treatment Combinations Using Zidovudine Plus Lamivudine Plus Indinavir in HIV-Infected Patients
  ClinicalTrials.gov Identifier: NCT00001084 - Completed
  HIV Infections
  
• Comparing the Effectiveness of a Triple Nucleoside Reverse Transcriptase Inhibitor Regimen Versus a Protease Inhibitor-Based Regimen In the Prevention of Mother-to-Child Transmission of HIV
  ClinicalTrials.gov Identifier: NCT00270296 - Recruiting
  HIV Infections
  
• Anti-HIV Drugs for Ugandan Patients With HIV and Tuberculosis
  ClinicalTrials.gov Identifier: NCT00078247 - Recruiting
  HIV Infections; Tuberculosis
  
• A Study of Saquinavir Soft Gelatin Capsules Plus Zidovudine Plus Lamivudine in the Treatment of HIV-1 Infected Patients Who Have Never Taken Anti-HIV Drugs
  ClinicalTrials.gov Identifier: NCT00002367 - Completed
  HIV Infections
  
• The Effectiveness of Indinavir Plus Zidovudine Plus Lamivudine in HIV-Infected Patients with No Symptoms of Infection
  ClinicalTrials.gov Identifier: NCT00002179 - Completed
  HIV Infections
  
• A Study to Evaluate Various Combinations of Anti-HIV Medications to Treat Early HIV Infection
  ClinicalTrials.gov Identifier: NCT00000919 - Completed
  HIV Infections
  
• Combination Treatment With and Without Protease Inhibitors for Women Who Begin Therapy for HIV Infection During Pregnancy
  ClinicalTrials.gov Identifier: NCT00017719 - Completed
  HIV Infections; Pregnancy